CARLSBAD, CA / ACCESSWIRE / July 28, 2020 / OPTEC International Inc., (OTC PINK:OPTI) OPTEC is a market leader in the development and distribution of (Ultra-Violet) UV-C & UV Germicidal Non-Toxic Sanitization and Disinfection using Chemical Free technologies and products. OPTEC is significantly helping in changing the Germicidal Sterilization & Disinfecting environment using UV-C Light and UV Products. Ultra-Violet light is now the Worlds most advanced solution for Killing Bacteria, Mites & Parasites whilst simultaneously de-activating 99% of Virus's in a non-chemical environment. The Company today announced the appointment of Original Shark Tank Investor and Global Infomercial Inventor Kevin Harrington to the Company's Advisory Board.

Kevin Harrington an innovator in infomercial marketing and one of the original Sharks on the hit TV show Shark Tank, and pioneer of the As Seen On TV Industry – Harrington has enabled countless entrepreneurs and business leaders to turn their ideas into reality. Throughout his corporate ventures, he has launched more than 500 products, driving over $5 billion in sales. In addition to being the Pioneer of the As Seen on TV Industry, Kevin co-founded as board member the Entrepreneur's Organization.

Twenty of his companies have each topped $100 million in revenue. (https://kevinharrington.tv)

Kevin Harrington stated, "OPTEC is an innovate leader in the Ultra-Violet disinfection technologies space that recently introduced the "OPTEC iWand" Personal Protection Equipment (PPE) product, obtaining consistent 5 Star reviews by consumers. The company is well positioned for high growth due to increased demand for the Company's advanced products to create safer and infection free environments at a time when these products are more needed than ever due to the novel viruses threatening Global population. I'm very excited to join the Company and leverage my knowledge in order to effectively bring their much needed new products to market, I believe OPTEC is well positioned for success due to its strong management, quality products, and experienced team. Recent research has revealed that not only are viruses an airborne threat to our health, and without pre-emptive measures in place continued exposure to these airborne viruses can also harm our physical and mental wellbeing. I am thrilled to be involved because I thoroughly believe in OPTEC and its products that successfully destroy harmful Bacteria and Viruses with a non-toxic chemical free solution".

Additionally, Mr. Steve Mandell – as an independent Director, was appointed to the OPTEC Advisory Board. Steve Mandell, an entertainment and sports attorney and serial entrepreneur who is engaged in international business. Steve has been involved with some of the biggest names in the sports and entertainment industry brokering thousands of transactions. Steve's company has also been a licensee of the NFL, MLB, CNN, NHL, Caesars and more. He has been involved in all aspects of business development, digital branding and marketing, Steve has produced many products and has experience in selling through all channels of distribution including some of the largest big box stores.

Mr. Mandell commented "I am honored to join the OPTEC Team as an Advisor. The OPTEC product lines have incorporated some of the most advanced and innovative technology in the world for non-toxic sterilization & Disinfection, and I look forward to being a part of this forward-thinking company. "

The OPTEC Advisory Board comprises of:

David Ojeda, Former Amazon Senior Director of Logistics and Distribution. Dr. John Parks Trowbridge MD (Stanford), Kevin Harrington, Shark Tank Original Investor, Steve Mandell, Harrington Group Expert Advisor.

OPTEC UVC Website: www.optecuvc.com

Additional Information Links about Ultra-Violet Technology.

https://www.dailymail.co.uk/health/article-8237137/Columbia-scientist-says-special-type-ultraviolet-light-secret-killing-coronavirus.html

https://www.cbsnews.com/news/new-york-city-subway-ultraviolet-light-coronavirus-mta/

https://www.ny1.com/nyc/all-boroughs/news/2020/05/19/mta-invests–1-million-in-uv-light-machines-to-clean-subways

https://abcnews.go.com/US/ultraviolet-light-zap-coronavirus-york-city-subways-buses/story?id=70770382

Safe Harbor Statement: Safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as Opti, OPTEC or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions, or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. OPTEC International Inc.

OPTEC International, Inc. Contact: info@optecintl.com

SOURCE: OPTEC International, Inc.

ReleaseID: 599134

ATLANTA, GA / ACCESSWIRE / July 28, 2020 / Aureus, Inc. (OTC PINK:ARSN) ("Aureus" or the "Company") (www.AureusNOW.com) an emerging leader in the food brand development industry which owns the Yuengling's Ice Cream brand ("Yuengling's Ice Cream" or "Yuengling's") (www.yuenglingsicecream.com) including all intellectual property and its distribution at select retail locations announced today that it will no longer need it's Regulation A as a source of funding for company operations.

"Bringing the financials current has enabled us to begin to complete the audits on some of the older periods. We begin posting these within the next few weeks, with an eye toward finishing by late Sept/early Oct. There have been several factors which have delayed us, we are excited to be clear of those and on track with this important step."

"In addition to the CARES act, it appears we are eligible for some other Stimulus programs. We are looking into those. This would give us an opportunity to further restructure the institutional debt. Since the completion of this acquisition, last August, we have reduced the overall debt by nearly $500k. Our goal for the next 12 months is to aggressively continue this balance sheet strengthening "Stated Everett Dickson CEO, Aureus.

About Aureus, Inc. The company focus is on acquiring specific assets in and related to the food industry. Aureus owns the assets and trademarks of the Yuengling's Ice Cream brand, and the exclusive right to market and sell the products of the brand. The goal of Aureus in the operation to consolidate all factors that are positive for the Yuengling brand into a synergistic success for Aureus shareholders as well as the next generation of Yuengling consumers.

About Yuengling's Ice Cream

Developed by American businessman Frank D. Yuengling, as a dairy business to help support the Yuengling family brewery during the 1920s Prohibition period, Yuengling's Ice Cream has a strong tradition of making exceptional gourmet ice cream products in central Pennsylvania. The fan-favorite brand continues advancing its legacy and its renowned dairy quality, by using locally sourced dairy ingredients that contain no added hormones. Yuengling's Ice Cream is a super-premium ice cream, which means it has a butterfat content of 14% or greater. In addition to having high butterfat, Yuengling's also has low overrun (or a lower amount of air). This makes the ice cream less whipped and much more dense. Yuengling's also is constantly working to keep its product as "clean" as possible, by using as few ingredients as necessary, and those that are used are of an extremely high quality. The brands Yuengling's is most similar to are Häagen-Dazs and Ben & Jerry's.

David Yuengling and Rob Bohorad revived the brand in 2014 and an American classic was re-born. In 2018, positioned for the brands next stage of development, Yuengling's Ice Cream forged a partnership with YIC – Online Distributors, to distribute the iconic ice cream brand online, now via Aureus. Today, Yuengling's Ice Cream is delivered directly to the doorsteps of its consumers across the nation.

The Yuengling's Ice Cream Corporation, as it has been since 1935, is a separately owned and run company from D. G. Yuengling and Sons, Inc Brewery.

Safe Harbor Statement

This communication contains statements that may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of US Highland, Inc, and members of its management as well as the assumptions on which such statements are based.

Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully, and the ability to complete before-mentioned transactions.

The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

For More Information

Contact & Media Inquiries:

Aureus.now@gmail.com
404.885.6045
www.AureusNow.com
Twitter: www.twitter.com/Aureus_inc

SOURCE: Aureus Incorporated

ReleaseID: 599017

Contact lenses manufacturers are optimizing supply chains and flexibility in operations to sustain production and ensure stock availability during the covid-19 pandemic.

DUBAI, UAE / ACCESSWIRE / July 29, 2020 / The contact lenses market is projected to surpass a valuation of US$ 8 Bn by 2020. The covid-19 outbreak has resulted in governments issuing social distancing guidelines in addition to encouraging the postponement of elective medical services, such as contact lens prescriptions. Also, heath concerns for workers in contract lens production and distribution facilities will moderately impact the global contact lenses market in the short term.

"The rising incidences of chronic eye ailments and a growing number of children afflicted by myopia are key factors aiding the adoption of contact lenses. Demographic factors such as an expanding population of geriatrics and diabetics will sustain market operations through and after the coronavirus crisis," states the FMI analyst.

Download a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-10714

Contact Lenses Market- Critical Takeaways

Hybrid contact lenses account for approximately half of global revenue owing to rising incidences of presbyopia and astigmatism.
Hydrogel is a popular, fast growing material for contact lenses, supported by higher oxygen permeability.
North America is a prominent market for contact lenses aided by a higher patient awareness level about eyecare preventable blindness issues.

Contact Lenses Market- Drivers

Higher consumer spending power, coupled with rising incidences of ophthalmologic ailments is a key growth driver.
Growing consumer bias towards branded and cosmetic contact lenses boosts adoption rates.

Contact Lenses Market- Restraints

Substantial differentiation in cost between products from branded and unbranded players hinders market growth.
Rising popularity of technologically advanced eye correction surgeries is hurting the demand for contact lenses.

Coronavirus Impact on Contact lenses Market

A substantial portion of global contact lenses production occurs in China. Numerous factory facilities continue to stay closed in the region during the coronavirus pandemic, which will impact supplies in the market for the near term. Other producers have had to run at limited operational capacity to comply with social distancing guidelines. Optimizing supply chains to maintain inventory stocks are critical to market players the world over. Telehealth facilities are also increasingly gaining importance for remote contact lens prescription services.

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-10714

Competitive Landscape

Manufacturers in the contact lenses market are largely investing in research and tech improvements for customization as per user needs. For instance, Johnson & Johnson are currently testing augmented reality technology for potential consumers to test out colored contact lenses. Menicon Co. Ltd., CooperVision Inc., Essilor International S.A., Johnson & Johnson Vision Care Inc., SEED Co. Ltd., Hoya Vision Care Co., ZEISS International, Bausch & Lomb Inc., and BenQ Materials Corp. are some of the leading contact lenses market players.

About the Study

The study offers readers a comprehensive assessment of the contact lenses market. Global, regional and national-level analysis of the latest trends influencing the contact lenses market is covered in this FMI report. The study provides insights according to product (soft lenses and gas permeable lenses), design (spherical, toric, multifocal, and others), wear (disposable and reusable), and sales channel (online and offline) in seven regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

We offer Tailor-made Solutions to fit your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-10714

Explore FMI's Coverage of the Retail & Consumer Products Industry

Ready to Mix Food Market– Get insights on the global ready to mix food market through FMI's report covering detailed quantitative and qualitative analysis for projection period 2014-2020.

Mobile Phone Accessories Market – FMI's exhaustive study on the global mobile phone accessories market covers the latest trends, innovations, key players, and popular strategies for the period 2019-2029.

Perfumes Market– Obtain detailed analysis on the perfumes market through FMI's report covering competitive analysis, key regions, and segmental analysis.

About Future Market Insights

Expert analysis, actionable insights, and strategic recommendations of the veteran research team at FMI helps clients from across the globe with their unique business intelligence requirements. With a repository of over a thousand reports and 1 million+ data points, the team has scrutinized the retail and consumer goods sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Contact:

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/contact-lenses-market
Press Release Source: https://www.futuremarketinsights.com/press-release/contact-lenses-market

SOURCE: Future Market Insights

ReleaseID: 599197

FORT PIERCE, FL / ACCESSWIRE / July 28, 2020 / Twin Vee PowerCats, Inc. (OTC PINK:TVPC), one of the largest production-based dual hull boat companies in the United States, will be featured in the August 2020 issue of the magazine Rudow's Fishtalk. Rudow's Fishtalk is a magazine that has served Chesapeake area fishing enthusiasts since 2017. "Rudow's Fishtalk will, among other things, include a stellar review of our 240 CC," Joseph Visconti, president of Twin Vee Powercats, Inc. said, "The team at Twin Vee is so honored to be included in a publication that celebrates the fishing lifestyle that we all love and, in part, design our boats around."

According to their website, Rudow's Fishtalk is a magazine that focuses in on Chesapeake Bay and Mid-Atlantic-based anglers and provides a "source for accurate, timely, how-to, where-to, local fishing knowledge…" The magazine offers fishers in the Mid-Atlantic region a publication that is "100-percent dedicated to fishing and fishing alone. One that's dedicated to bringing them timely information on how to catch more and bigger fish." Published by the SpinSheet Publishing Company, Rudow's Fishtalk is helmed by Lenny Rudow, a 20-plus year veteran writer specializing in fishing, boating, and marine electronics. In its August issue, the magazine examined a couple of new fishboats, including the 240 CC Powercat.

240 CC Powercat

Rudow's Fishtalk Reviews the 240 CC Powercat

A few years ago, Twin Vee Powercats, Inc. began work on designing and manufacturing new boat models that would appeal to a wider consumer base and allow more potential boat buyers the opportunity to experience the kind of smooth ride Twin Vee has become known for. Twin Vee launched the 24-foot center console power catamaran in 2019, which has been received very well by customers and critics alike. The Rudow's Fishtalk article showcases the boat in its review.

Touting the 240 CC Powercat's features in his article, Lenny Rudow goes over the best-in-class amenities onboard. Everything from the 240 CC's wide 8 foot and 8 inch-wide beam, the abundant seating throughout the deck, and the twin Suzuki outboard motors (115s, 140s, or 150s) that can be affixed on 12-inch Atlas jack plates. Moreover, Rudow states in his article that he loves "that six flush-mount gunwale rodholders come standard instead of the usual four, the transom livewell holds a whopping 40 gallons . . . When you put those goodies to use we have no doubt you'll do your best to fill the in-deck macerated fishboxes flanking the console…"

Visconti adds that the 240 CC Powercat was designed and built with an all-composite body that offers superior stability to v-shaped hulls. "The amenities that were featured in the article, as well as the others not mentioned, all come together to create a unique and extraordinary boat that exemplifies the great strides our company has taken in recent years," explains Visconti.

240 CC Powercat featured in Rudow's Fishtalk August 2020 Issue

The Rudow's Fishtalk article encourages its readers to test drive a 240 CC, especially if all they've owned were V-shaped hulled boats, stating "Just wait for a day with 20-knot gusts, and take one for a sea trial. Your aching back will thank you for it." Preston Yarborough, Director of Product Development and Vice President for Twin Vee, believes that when customers get behind the wheel of a 240 CC, they will see for themselves that it delivers a stable ride (even in turbulent waters), regardless of one's familiarity with operating a twin-hull boat. "Power cats are incredibly simple to operate. Once you learn the basics of keeping a proper trim, you will be well on your way to becoming an expert," stated Yarborough. "In fact, experienced boaters will tell you that learning to drive a catamaran was easy and they'll never go back to a monohull because of the benefits of owning a power cat," Yarborough adds.

240 CC Powercat heading out to sea

The 240 CC Powercat Life

In addition to the attention from the Rudow's Fishtalk article, Twin Vee's 240 CC was also featured in Center Console Life Magazine and Florida Sportsman Magazine in 2019. Visconti and the Twin Vee team are delighted to see the 240 CC get recognized by authorities in the recreational boating world as well as customers who have rode in and purchased one. "The 240 CC is just one example of Twin Vee's commitment to designing and manufacturing innovative and best-in-class boats. We want to constantly push the boundaries and improve the way our customers live, work, and play on the water," explains Visconti.

Those interested in reading Rudow's Fishtalk's review of Twin Vee's 240 CC Powercat will be able to find it here when it is released. You can also read more about Rudow's Fishtalk, including their back issues, at fishtalkmag.com.

More information on the 240 CC Powercat can be found on Twin Vee's website here.

About Twin Vee PowerCats, Inc.

Headed by CEO Joseph Visconti, originally founded in 1994, the company designs, manufactures, and sells recreational and commercial twin-hull power boats under the Twin Vee brand name. Over the past 26 years, the company has concentrated on perfecting the high-speed twin-displacement hull design, also known as a "catamaran powerboat." For more information, go to www.twinvee.com or visit Twin Vee Powercats, Inc.'s Facebook page.

Contact:

Joseph Visconti
info@twinvee.com
(772) 429-2525

SOURCE: Twin Vee PowerCats, Inc.

ReleaseID: 599102

BOHEMIA, NY / ACCESSWIRE / July 28, 2020 / AmpliTech Group, Inc. (OTCQB:AMPG): AMPG CEO Fawad Maqbool stated today "In the midst of the Covid-19 pandemic, AMPG is proud to announce that it has continued to follow its strategy for the identification of key elements of today's technology revolution, and has leveraged its technical expertise and experience to align its product portfolio and IP with these innovations. These technologies are evolving just as the previous "dot-com",bubble, fiber, 1G to 4G as well as standard Wi-Fi, which led to the FAANG group of companies we know so well today. Similarly, we believe we are at the knee of "hockey-stick" growth that is purportedly bigger than ALL the previous developments COMBINED. We hope our existing and newly developed products will make AMPG an integral part of these global multi-trillion dollar rapidly evolving markets for the 21st century." The Company noted that it plans to be a catalyst in the enhancement, development, and distribution of breakthroughs in the following significant sizeable markets:

Target Markets for AMPG

High Speed Terrestrial and Satellite Terminals (SATCOM, "Internet in the Sky")
5G/Wi-Fi6E, and 6G wireless infrastructure (Cellular Base Stations, Small Cells, Private Wi-Fi Networks)
IoT (Internet of Things) Eventually everything gets "connected" as billions of devices become smart and enabled by the 5G Ecosystem
Cloud Farms, Big Data, and MEC architecture
Quantum Supercomputers/Quantum Research
Deep Space Astronomy
Autonomous Self-Driving Vehicles
Telemedicine, AR/VR (Augmented and Virtual Reality)
Drones, UAVs (Unmanned Aerial Vehicles)
Cyber-security
Military/Defense ECM/EW

The Company has made significant breakthroughs in its core low noise amplifier products, as evidenced by its recent filing of various patents. These amplifiers are the "building blocks" of virtually every wireless communication system and the ever-growing demand for higher performance and quality in many of these communication systems has made AMPG products more popular. This is where the Company has excelled for many years, but the best performance and fidelity was only required in high-end systems such as radar, test equipment, and small research projects. "We believe we have "perfect storm" conditions today as the rising demand for better and faster communication equipment is the gateway to usher in many other technologies (listed above). Now, the obscure applications have become the mainstream solution to many developing technologies and AMPG has now focused on making its products mainstream and providing staple solutions." The Company lists the following milestones for achieving its goals throughout 2019 and into 2020:

Important Milestones for 2019 and 2020

Re-organization of BOD
Obtained non-dilutive financing/funding
Executed first accretive acquisition (Specialty Microwave)
Expanded Technical and Sales teams with key engineering and executive talent
Engaged Maxim Group, LLC to re-IPO and try to up-list to Nasdaq
Engaged Investment banking consultant
Expanded its IP portfolio with assets from acquisition as well as filing new patents
Expanded customer base by adding OneWeb, CNN, Fox News, Globecomm, General Dynamics, and many other notable Specialty Microwave customers
Developed and expanded joint product line offering by creating up-selling and cross-selling opportunities for AMPG and Specialty to larger customer base
Developed new cryogenic amplifiers for use in quantum computing and research
Generated Pro-Forma Revenues of $4 million, (post acquisition)
Uploaded new product list for U.S. Government GSA (General Services Administration) leading to increased RFQ activity on $500,000 GSA award
Increased Company market cap from $2.7 million to ~$8 million

Upcoming Guidance

Barring the latent effects of the Covid-19 pandemic, the Company cited its achievements and continued focus on target markets as an indication of its progress and dedication to growth. The Company remains committed to its investors and shareholders, and has taken deliberate and careful steps to steadfastly scale up its business model from a low volume research and development company, to blazing a trail and becoming a cornerstone of breakthrough and mainstream technology.

About AmpliTech Group, Inc.

AmpliTech Group, Inc. designs, develops, and manufactures custom and standard state-of-the-art RF components for the Domestic and International, SATCOM, Space, Defense and Military markets. These designs cover the frequency range from 50 kHz to 40 GHz – eventually, offering designs up to 100 GHz. AmpliTech also provides consulting services to help with any microwave components or systems design problems. Our steady growth over the past 13+ years has come about because we can provide complex, custom solutions for nearly ANY custom requirements that are presented us. In addition, we have the best assemblers, wires, and technicians in the industry and can provide contract assembly of customers' own designs. Click here to view AmpliTech video. Website: http://www.AmpliTechinc.com

Forward-looking Statements

This release contains statements that constitute forward-looking statements. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.

CONTACT:

Fawad Maqbool, CEO
AmpliTech Group, Inc.
(631) 521-7831

Twitter: https://twitter.com/AmpliTechAMPG
Instagram: https://www.instagram.com/amplitechampg/
Facebook: https://www.facebook.com/AmpliTechInc

SOURCE: AmpliTech Group, Inc.

ReleaseID: 598984

Resumption of its PLENITUDE© clinical trial on-time;
CAUMZ™ manufacturing set to begin in USA to allow start of clinical trials;
QIXLEEF™ metabolite mapping study to be complete in Q3 2020

OTTAWA / ACCESSWIRE / July 28, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced that the long awaited resumption of its PLENITUDE© clinical trial is on time and set to commence in Q3 2020. In addition, the Corporation expects to resume the ReBorn© clinical trial to bring CAUMZ™ to the market as an alternative to opioids for breakthrough pain.

QIXLEEF™ UPDATE

The Plenitude© trial, which will involve ten clinical sites across the United States, is set to begin site initiation study specific procedures in August 2020. This is important to ensure the principal investigator and study staff understand the study protocol, that all the operational steps have been implemented, and that specific roles and responsibilities have been clearly defined and understood by all parties. Patient recruitment and enrollment will begin as soon as the sites receive the GMP grade cannabis drug product from Aphria. Plenitude© is on target to deliver the initial drug dose to patients in the clinical trial by September 2020.

QIXLEEF™ CANNABINOID METABOLIC PROFILE STUDY IN HUMANS:

On April 2, 2020, Tetra announced the launch of a study to map out the levels of cannabinoid metabolites (e.g., 7-COOH-CBD), cannabinoid precursors (e.g., CBGA) and minor cannabinoids (e.g., CBN) in the plasma of humans that had smoked or vaporized QIXLEEF™. This study is advancing as planned and we expect to receive the first data by end of August, beginning of September. Tetra is on track to complete this study as promised in Q3 2020. Dr. Guy Chamberland, CEO and CRO of Tetra commented, "We look forward to the 7-COOH-CBD metabolite data as the levels of this metabolite could provide an explanation of the recognized safety profile for the inhalation route of administration of the drug product through the Mighty Medic device, relative to the oral dosing route. If this is the case, Tetra believes that its inhalation technology could provide a safer solution to avoid liver toxicity in patients seeking CBD-based therapies."

CAUMZ™ UPDATE:

Over the last six months, Tetra has been planning for the manufacturing of CAUMZ™ at an undisclosed site in the USA. This project was initiated as part of Tetra's risk mitigation framework aimed at reducing delays to export CAUMZ™ to the USA. The Corporation expects to complete the manufacturing set-up and required GMP validations prior to the start of the ReBornã trial. Guy Chamberland, commented, "Once the USA and Canadian manufacturing facilities are fully operational and validated, Tetra will be able to accelerate the clinical development of the CAUMZ™ technology product line. This is also a critical path for completing the regulatory requirements for marketing approval. Subject to the outcome of the metabolite profiling study, which is ongoing, this validated manufacturing process would allow the Corporation to accelerate any CAUMZ™ technology product rapidly for patients."

About Tetra Bio-Pharma

Tetra Bio-Pharma (TSXV:TBP) (OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed and approved, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.

For more information visit: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company's business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company's research and development strategies, including the success of this product or any other product, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

For further information, please contact Tetra Bio-Pharma Inc.:

Investor Contact:

Tetra Bio-Pharma Inc.
Dr. Guy Chamberland, M.Sc., Ph.D.
Chief Executive Officer
Phone: + 1 (833) 977-7575
investors@tetrabiopharma.com

Alpha Bronze, LLC
Mr. Pascal Nigen
Phone: + 1 (646) 255-0433
tetra@alphabronze.net

Media Contact:

energi PR
Ms. Carol Levine APR, FCPRS
Phone: + 1 (416) 425-9143 ext. 226
Mobile: + 1 (514) 703-0256
carol.levine@energipr.com

SOURCE: Tetra Bio-Pharma

ReleaseID: 599120

SAN DIEGO, CA / ACCESSWIRE / July 28, 2020 / Nascent Biotech, Inc. (OTCQB:NBIO), announced today it has entered into a research collaboration with Syracuse University to further the development of Pritumumab, a unique monoclonal antibody that binds to cell-surface vimentin, for potential use in COVID-19 treatment.

Alison Patteson, an assistant professor of physics at Syracuse University, will test to see if Pritumumab has the potential to block SARS-CoV-2 (SARS2), the virus responsible for COVID-19, from entering cells. According to Patteson, research shows that SARS2 may be traveling into cells by way of a receptor known as cell-surface vimentin (CSV). This ia a protein found on the cell surface, similar to vimentin, which is a key internal structural protein present in many cell types. Vimentin is known for its cage-like structure which protects the cell against damage.

"Our hope is that when we treat cells with Pritumumab, it will bind to CSV, and effectively block the SARS2 virus from entering the cell," says Patteson. "An antibody that could block the entry of SARS2 into the cell could be a monumental step in the fight against COVID-19."

Patteson will test the hypothesis on mouse embryo fibroblast cells and lung airway epithelial cells to determine if the antibody will block the uptake of SARS2. Using a cell in which vimentin has been knocked out, the results will provide an important control of Pritumumab effects.

Nascent Biotech Chief Medical Officer over Viral Research, Dr. Navpaul Singh said, "This collaboration will determine if Pritumumab can effectively block SARS2 in an animal mouse model. It will also gauge Pritumumab's ability to bind vimentin in a live model."

About Nascent Biotech, Inc.

Nascent Biotech, Inc is a clinical-stage biotech company engaged in the development of monoclonal antibodies to be used in the treatment of various cancers. Its products are not commercially available. For further information please visit our website www.nascentbiotech.com.

Safe Harbor:

Statements in this press release about our future expectations constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and our actual results could differ materially from expected results. These risks and uncertainties include, without limitation, Nascent Biotech Inc's ability to target the medical professionals; Nascent Biotech Inc's ability to raise capital; as well as other risks. Additional information about these and other factors may be described in the Nascent Biotech Inc's Form 10, filed on May 2, 2015, and future subsequent filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

For further information, please contact:

Sean Carrick
President |CEO
Nascent Biotech, Inc
6330 Nancy Ridge Dr
Suite 105
San Diego CA 92121
(612) 961-5656
Sean.carrick@nascentbiotech.com

SOURCE: Nascent Biotech Inc.

ReleaseID: 598481

Integration of the largest remote sensing imagery data in the Agrilyze platform poised to improve the agricultural outcome for many growers in North America

SAN LEANDRO, CA / ACCESSWIRE / July 28, 2020 / TerrAvion, the largest provider of aerial imagery for agriculture, announces the new partnership with Agrilyze enabling users to seamlessly implement their aerial imagery into the Agrilyze app to benefit fully from its data analytics and other precision farming tools. Through this partnership, Agrilyze's platform will be using TerrAvion high-resolution imagery to analyze plant health, watering needs, input management for farms to make optimized decisions.

'We are thrilled that the outstanding platform Agrilyze is enabling customers to take advantage of their advanced technology to improve the outcomes on their farms", says Andrew Pylypchuk, Senior Vice President Enterprise at TerrAvion, "Growers need to continuously manage their farm during the season and adding subscription imagery to visualize the information received from many different sources in Agrilyze will enable them to do so more effectively."

TerrAvion's high-resolution imagery connected in the Agrilyze platform offers customers an affordable way to get accurate and timely image data to operate at high efficiency with optimum accuracy during the whole season," says Vladimir Grigorescu, VP of Sales and Marketing at Agrilyze. "We are very excited to partner with TerrAvion and expand our services beyond the Fraser Valley in Canada."

Agrilyze is home-grown within the Fraser Valley, BC, Canada, and is positioned to become a leading-edge, cloud-hosted, data-driven analytics platform that focuses on improving the agriculture industry's outcome. Agrilyze, through advanced technology built by iOpen Technologies, blends, agricultural expertise, premium geospatial data, imagery, and Ai to improve productivity, ROI, and profitability. Now ready to expand into other regions, TerrAvion has been chosen as the provider for high-resolution subscription imagery data used to provide the plant health, water management, and input management for Agrilyze customers. Agrilyze aggregates the premium data in one easy-to-use platform enabling precision agriculture by combining leading-edge technologies such as Ai and IoT.

About TerrAvion:
TerrAvion helps farms take a high-­tech approach to improve yield and revenue, with the largest cloud­-based aerial imaging and data analytics service for agriculture. TerrAvion provides growers from small family farms to the largest agribusinesses with current images and data that accurately detail the conditions of every acre, helping identify problems early before they impact yield. Founded in 2013, TerrAvion's investors include Merus Capital, Initialized Capital, 10x Group, and Y Combinator. For more information, visit www.terravion.com or follow @TerrAvion on Twitter, Facebook, or LinkedIn.

About Agrilyze:
Agrilyze is a data analytics and insights platform for the agriculture industry by i-Open Technologies, a leader in geospatial technology and AI solutions. Agrilyze helps farmers reduce crop loss, manage work efficiently between teams, centralize all farm data for better insights, and remain compliant to environmental regulations.

MEDIA CONTACT:
Ria Van Hoef
TerrAvion
+1 510 399 8796
ria@terravion.com

SOURCE: TerrAvion

ReleaseID: 599117

VANCOUVER, BC / ACCESSWIRE / July 28, 2020 / Zinc8 Energy Solutions Inc. ("Zinc8" or the "Company") (TSXV:ZAIR) is pleased to announce that it has entered into an engagement with Incite Capital Markets Inc. ("Incite") of Vancouver, British Columbia, Canada to provide investor relations and capital markets advisory services to the Company.

Incite will initiate and strengthen relationships with the financial community including shareholders, investors and other stakeholders for the purpose of increasing awareness of the Company, its technology and its activities. A key part of this mandate will focus on increasing visibility and building relationships with analysts, investment dealers, financial advisors and other investment professionals. Incite will also spearhead the Company's investor relations initiatives, including its participation in investment conferences, planning and organization of investor events, and assist in the dissemination of Company news and information to Zinc8 stakeholders. Incite Capital and its executives currently hold approximately 5% of the issued and outstanding shares of Zinc8 Energy Solutions.

The agreement with Incite has an initial term of 12 months, for which Incite will be paid a monthly fee of $15,000 and will be granted an option to acquire 200,000 common shares of Zinc8 at a price of $0.20 per share. The options will be exercisable for a period of three years from the date of grant and will vest monthly over the first 12 months of the contract.

About Incite Capital Markets

Vancouver, BC-based Incite Capital Markets is an independent, innovative and trusted capital markets advisory corporation. Built on a proven track record of over 20 years' experience helping companies achieve the best results possible, Incite provides expertise in capital markets, corporate communications, and investor and media relations. In addition to strategic insights, Incite invests in small to mid-sized technology companies. This unique and specialized synergy where corporate finance and communications meet, is an advantage for any company looking to elevate their profile. For further information, please visit www.incitecapitalmarkets.com.

About Zinc8 Energy Solutions Inc.

Zinc8 has assembled an experienced team to execute the development and commercialization of a dependable low-cost zinc-air battery. This mass storage system offers both environmental and efficiency benefits. Zinc8 strives to meet the growing need for secure and reliable power.

To watch a short video outlining Zinc8's technology, please visit:

https://zinc8energy.com

More about the Zinc8 Energy Storage System (ESS)

The Zinc8 ESS is a modular Energy Storage System designed to deliver power in the range 20kW – 50MW with capacity of 8 hours of storage duration or higher. With the advantage of rechargeable zinc-air flow battery technology, the system can be configured to support a wide range of long-duration applications for microgrids and utilities. Since the energy storage capacity of the system is determined only by the size of the zinc storage tank, a very cost-effective and scalable solution now exists as an alternative to the fixed power/energy ratio of the lithium ion battery.

Technology

The Zinc8 ESS is based upon unique patented zinc-air battery technology. Energy is stored in the form of zinc particles, similar in size to grains of sand. When the system is delivering power, the zinc particles are combined with oxygen drawn from the surrounding air. When the system is recharging, zinc particles are regenerated, and oxygen is returned to the surrounding air.

Applications

The flexibility of the Zinc8 ESS enables it to service a wide range of applications. Typical examples include:

Smoothing energy derived from renewable sources such as wind and solar
Commercial/Industrial backup replacing diesel generators
Industrial and grid scale, on-demand power for peak shaving and standby reserves
Grid-scale services such as alleviating grid congestion, deferring transmission/distribution upgrades, energy trading and arbitrage, and increasing renewable energy penetration.

Architecture

The Zinc8 ESS is designed according to a modular architecture that enables a wide variety of system configurations to be created from a small number of common subsystems. Each subsystem implements a single element of the technology:

The Zinc Regeneration Subsystem (ZRS) provides the recharging function
The Fuel Storage Subsystem (FSS) provides the energy storage function
The Power Generation Subsystem (PGS) provides the discharging function

Notice Regarding Forward Looking Statements

This news release contains certain statements or disclosures relating to Zinc8 Energy Solutions that are based on the expectations of its management as well as assumptions made by and information currently available to Zinc8 Energy Solutions which may constitute forward-looking statements or information ("forward-looking statements") under applicable securities laws. All such statements and disclosures, other than those of historical fact, which address activities, events, outcomes, results or developments that Zinc8 Storage anticipates or expects may or will occur in the future (in whole or in part) should be considered forward-looking statements.

Forward looking statements in this press release include that we can execute the development and commercialization of a dependable low cost zinc-air battery; that our mass storage system offers both environmental and efficiency benefits; and that we can help meet the needs for secure and reliable power. Zinc8 Energy Solutions believes the material factors, expectations and assumptions reflected in the forward-looking statements are reasonable at this time, but no assurance can be given that these factors, expectations and assumptions will prove to be correct. The forward-looking statements included in this news release are not guarantees of future performance. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements including, without limitation: that our technology fails to work as expected or at all; that our technology proves to be too expensive to implement broadly; that customers do not adapt our products for being too complex, costly, or not fitting with their current products or plans; our competitors may offer better or cheaper solutions for battery storage; general economic, market and business conditions; increased costs and expenses; inability to retain qualified employees; our patents may not provide protection as expected and we may infringe on the patents of others; and certain other risks detailed from time to time in Zinc8 Energy Solution's public disclosure documents, copies of which are available on the Company's SEDAR profile at www.sedar.com. Readers are cautioned that the foregoing list of factors is not exhaustive and are cautioned not to place undue reliance on these forward-looking statements.

The forward-looking statements contained in this news release are made as of the date hereof and the Company undertakes no obligations to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

Neither the CSE nor any Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For more information please contact:

Incite Capital Markets
Kristian Schneck / Eric Negraeff
Ph: 604.493.2004
Zinc8 Energy Solutions Inc.|

Mark Baggio
Ph: 647-909-5053
Email: investors@zinc8energy.com

SOURCE: Zinc8 Energy Solutions Inc.

ReleaseID: 599169

CHIBOUGAMAU, QC / ACCESSWIRE / July 28, 2020 / Delta Resources Limited ("Delta" or the "Company") (TSXV:DLTA) (OTCBB:GOLHF) (Frankfurt:6G01) is pleased to announce initial results from a rock sampling program at the Snowfall Gold Discovery (see Delta press release November 26, 2019).

In June 2020, Delta geologists with the help of a team of consultants from Laurentia Exploration and local prospectors, carried-out a bedrock mapping and sampling program coupled with boulder tracing at the Delta-2 property in Chibougamau, Quebec. Part of the program covered the site of the Snowfall Gold occurrence, a discovery made through prospecting in November 2019 (see Delta press release November 26, 2019). Two additional mineralized outcrops have been located at the site and assay results are as follows:

Easting

Northing

Gold g/t

Silver g/t

Copper %

Material Sampled

*Snowfall Outcrop:

549 944

5 496 974

11.45

n/a

n/a

Composite vein-host

10.10

n/a

n/a

Host rock gossan

9.97

n/a

n/a

Quartz vein

5.62

n/a

n/a

Host rock material

AB-05 Outcrop:

549 856

5 496 922

5.59

7.6

n/a

Altered basalt

**007 Outcrop:

549 987

5 496 790

8.66

190

3.94

Quartz-sulphide vein

007 Boulder:

549 980

5 496 780

2.70

47.7

n/a

Quartz-sulphide vein

*Previously reported November 26, 2019.
**Grab sample from initial trench July 2020.

Mineralized samples have now been discovered over a north-south direction of 184 metres and 131 metres in the east-west direction. Also new at Snowfall are the high copper and silver values.

In addition to sampled outcrops, two mineralized boulders of quartz vein with trace disseminated chalcopyrite have also been discovered at the site; pointing to a nearby source to the north-northeast of the gold occurrence. Assays values of these boulders are as follows:

Easting

Northing

Gold g/t

Silver g/t

Copper %

Material Sampled

AT-116.f

549 980

5 496 909

0.44

17.7

n/a

Quartz vein Boulder

AT-116.g

549 984

5 496 917

1.25

5.6

n/a

Quartz vein Boulder

Michel Chapdelaine, Vice-President of Exploration commented as follows:

"This is a totally new discovery in a well-known mining camp. The target area surrounding the Snowfall Gold-Copper occurrence covers an area well over 5 square kilometers and not one historical drill hole is reported in the area."

André Tessier, President and CEO commented as follows:

" We have a tremendous opportunity to make a significant discovery in a mature camp where multiple deposits already exist. Our team of geologists is extremely excited and motivated by this new discovery. We're looking forward to receiving the results of our channel sampling shortly."

As reported on July 9th, 2020, Delta is currently carrying out a mechanical trenching program at Delta-2, which includes the Snowfall Gold occurrence. Mechanical trenching at Snowfall uncovered strong and pervasive alteration zones hosting different mineralized quartz veins at the contact of the La Dauversière Pluton. Three (3) trenches were completed spaced by more than 150 meters from each other. Channel sampling work has been completed and assays are pending.

Targets at the Delta-2 project consist of magmatic-hydrothermal gold deposits related to the La Dauversiere Pluton, such as the Joe Mann past producer (1956-2007: 1.173 million ounces of gold at a grade of 8.26 g/t Au, 607,000 ounces of silver at 5 g/t Ag and 28.7 million pounds of copper at 0.25% Cu) (Source: Technical Report on the Joe Mann Mining Property dated January 11, 2016, prepared by Geologica Inc.). In addition, Delta is targeting VMS mineralization similar to the Lemoine Mine which is located 1.5 kilometre north of the property. Between 1975 and 1983, the extraordinarily rich Lemoine Mine produced 757,585 tonnes of ore grading 9.52% Zn, 4.18% Cu, 4.56 g/t Au and 82.26 g/t Ag (Source: www.sigeom.mines.gouv.qc.ca).

Analytical Protocol and Qualified Person

Geochemical analyses were performed by Laboratoire Expert Inc, Rouyn-Noranda. Gold geochemical analyses were performed by fire assay with finish by Atomic Absorption. For samples grading over 3 g/t Au, the sample was re-analyzed by fire assay with gravimetric finish. Silver and base metal assays were analyzed by aqua regia (ICP).

The quality assurance and quality control protocol include insertion of blank or standard in addition to the regular insertion of blank, duplicate, and standard samples accredited by Laboratoire Expert during the analytical process.

Michel Chapdelaine, P.Geo. and Vice-President of Exploration at Delta Resources Limited is a Qualified Persons as defined by NI-43-101 and is responsible for the technical information presented in this press release.

About Delta Resources Limited

Delta Resources Limited is a Canadian mineral exploration company focused on growing shareholder value through the acquisition of high-potential gold and base-metal projects in Canada, exploring these projects with state-of-the-art methods, and potentially developing these projects into mines.

Delta is currently exploring its Eureka Gold Discovery in the Thunder Bay area (Delta-1) and its Delta-2 Gold-Polymetallic Property in the Chibougamau Mining District of Quebec.

Delta also owns a 100% interest in the Bellechasse-Timmins gold deposit in southeastern Quebec. On July 3rd, 2020, Delta announced the sale of the Bellechasse-Timmins project.

The Company continues to focus on building upon its strong portfolio of mineral exploration properties with a high potential for economic discoveries in Canada.

ON BEHALF OF THE BOARD OF DELTA RESOURCES LIMITED.

Andre C. Tessier
President, CEO and Director
www.deltaresources.ca

We seek safe harbor. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The TSX Venture Exchange has not approved nor disapproved of the information contained herein.

For Further Information:

Delta Resources Limited
Frank Candido, Chairman and Vice-President Corporate Communications
Tel: 514-969-5530
fcandido@deltaresources.ca

or

Andre Tessier, President and CEO
Tel: 613-328-1581
atessier@deltaresources.ca

Cautionary Note Regarding Forward Looking Information

Some statements contained in this news release are " "forward looking information" within the meaning of Canadian securities laws. Forward looking information include, but are not limited to, statements regarding the use of proceeds of the non-brokered private placement and payment of the debt settlements. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", "believes" or variations of such words and phrases (including negative or grammatical variations) or statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" or the negative connotation thereof. Investors are cautioned that forward-looking information is inherently uncertain and involves risks, assumptions and uncertainties that could cause actual facts to differ materially. There can be no assurance that future developments affecting the Company will be those anticipated by management. The forward-looking information contained in this press release constitutes management's current estimates, as of the date of this press release, with respect to the matters covered thereby. We expect that these estimates will change as new information is received. While we may elect to update these estimates at any time, we do not undertake to update any estimate at any particular time or in response to any particular event.

SOURCE: Delta Resources Limited

ReleaseID: 599163